Lv2, a novel postentry restriction, is mediated by both capsid and envelope
- PMID: 14747565
- PMCID: PMC369432
- DOI: 10.1128/jvi.78.4.2006-2016.2004
Lv2, a novel postentry restriction, is mediated by both capsid and envelope
Abstract
The characterization of restrictions to lentivirus replication in cells identifies critical steps in the viral life cycle and potential therapeutic targets. We previously reported that a human immunodeficiency virus type 2 (HIV-2) isolate was restricted to infection in some human cells, which led us to identify a step in the life cycle of HIV-2 detected after reverse transcription but prior to nuclear entry. The block is bypassed with a vesicular stomatitis virus glycoprotein G (VSV-G) envelope (A. McKnight et al., J. Virol. 75:6914-6922, 2001). We hypothesized that, although the restriction is apparent at a post-reverse transcription step, the lack of progress results from a failure of the virus to reach a cellular compartment with access to the nucleus. Here we analyzed molecular clones of the restricted virus, MCR, and an unrestricted virus, MCN. Using sequence analysis and gene swapping, we mapped the viral determinants to gag and env. Site-directed mutagenesis identified a single amino acid at position 207 in CA to be responsible for the gag restriction. Pseudotype experiments indicate that this step is also important for the infection of cells by HIV-1. The HIV-1 NL4.3 core is restricted if supplied with a restricted MCR envelope but not with VSV-G. Also the NL4.3 envelope rescues the restricted core of HIV-2 MCR. Abrogation experiments with MLV demonstrate that the restriction is distinct from Fv1/Ref1/Lv1. We propose that this represents a new lentiviral restriction, Lv2. Thus, the envelope and capsid of HIV act to ensure that the virus is delivered into an appropriate cellular compartment that allows postentry events in viral replication to proceed efficiently.
Figures
![FIG. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/369432/bin/zjv004041247001a.gif)
![FIG. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/369432/bin/zjv004041247001a.gif)
![FIG. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/369432/bin/zjv0040412470002.gif)
![FIG. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/369432/bin/zjv004041247003a.gif)
![FIG. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/369432/bin/zjv004041247003a.gif)
![FIG. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/369432/bin/zjv0040412470004.gif)
![FIG. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/369432/bin/zjv0040412470005.gif)
![FIG. 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/369432/bin/zjv0040412470006.gif)
Similar articles
-
The innate immune factor RPRD2/REAF and its role in the Lv2 restriction of HIV.mBio. 2023 Dec 19;14(6):e0257221. doi: 10.1128/mbio.02572-21. Epub 2023 Oct 26. mBio. 2023. PMID: 37882563 Free PMC article. Review.
-
A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.Retrovirology. 2010 Oct 7;7:81. doi: 10.1186/1742-4690-7-81. Retrovirology. 2010. PMID: 20929586 Free PMC article.
-
Human TRIM5alpha mediated restriction of different HIV-1 subtypes and Lv2 sensitive and insensitive HIV-2 variants.Retrovirology. 2006 Nov 6;3:79. doi: 10.1186/1742-4690-3-79. Retrovirology. 2006. PMID: 17087820 Free PMC article.
-
Role of HIV-2 envelope in Lv2-mediated restriction.Virology. 2005 Feb 5;332(1):347-58. doi: 10.1016/j.virol.2004.11.025. Virology. 2005. PMID: 15661166
-
HIV-1 gag proteins: diverse functions in the virus life cycle.Virology. 1998 Nov 10;251(1):1-15. doi: 10.1006/viro.1998.9398. Virology. 1998. PMID: 9813197 Review.
Cited by
-
Capsid-dependent lentiviral restrictions.J Virol. 2024 Apr 16;98(4):e0030824. doi: 10.1128/jvi.00308-24. Epub 2024 Mar 18. J Virol. 2024. PMID: 38497663 Free PMC article. Review.
-
The innate immune factor RPRD2/REAF and its role in the Lv2 restriction of HIV.mBio. 2023 Dec 19;14(6):e0257221. doi: 10.1128/mbio.02572-21. Epub 2023 Oct 26. mBio. 2023. PMID: 37882563 Free PMC article. Review.
-
Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor.Retrovirology. 2023 Aug 22;20(1):15. doi: 10.1186/s12977-023-00629-4. Retrovirology. 2023. PMID: 37608289 Free PMC article.
-
Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor.bioRxiv [Preprint]. 2023 Mar 25:2023.03.24.534139. doi: 10.1101/2023.03.24.534139. bioRxiv. 2023. Update in: Retrovirology. 2023 Aug 22;20(1):15. doi: 10.1186/s12977-023-00629-4. PMID: 36993223 Free PMC article. Updated. Preprint.
-
Imaging Flow Cytometry and Confocal Immunofluorescence Microscopy of Virus-Host Cell Interactions.Front Cell Infect Microbiol. 2021 Oct 12;11:749039. doi: 10.3389/fcimb.2021.749039. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34712624 Free PMC article. Review.
References
-
- Aagaard, L., J. G. Mikkelsen, S. Warming, M. Duch, and F. S. Pedersen. 2002. Fv1-like restriction of N-tropic replication-competent murine leukaemia viruses in mCAT-1-expressing human cells. J. Gen. Virol. 83:439-442. - PubMed
-
- Best, S., P. Le Tissier, G. Towers, and J. P. Stoye. 1996. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382:826-829. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous